Innovation

ENDRA Life Sciences Swings To Q2 Profit On Digital Asset Gains Ahead Of Noble Africa Merger

By Amit Chowdhry ● Aug 19, 2026

ENDRA Life Sciences reported Q2 2026 net income of approximately $160,000, compared with a $1.2 million loss a year earlier, as roughly $1.6 million of other income from its digital-asset treasury more than offset the company's operating loss ahead of its proposed merger with Noble Africa.

WeTouch Technology: Net Income Jumps 25.5% To $6 Million As Automotive And Medical Touchscreen Demand Grows

By Amit Chowdhry ● Aug 19, 2026

WeTouch Technology reported first-half 2026 net income of $6 million, up 25.5% year over year, as demand increased across its touchscreen portfolio, with automotive and medical applications leading growth.

CEL-SCI Signs Saudi Arabia Multikine Commercialization Deal With 50/50 Net Revenue Split

By Amit Chowdhry ● Aug 19, 2026

CEL-SCI signed an agreement with Saudi Amarox Co. covering the registration, commercialization, and distribution of Multikine in Saudi Arabia, with the companies agreeing to a 50/50 split of net product sales revenue if the investigational cancer therapy receives the required regulatory approvals.

Greenland Mines: Q2 Loss Narrows To $3.7 Million Following Pivot From Biotech Into Mining

By Amit Chowdhry ● Aug 19, 2026

Greenland Mines reported a Q2 2026 net loss of $3.69 million, narrowing from $4.09 million a year earlier, during its first full quarter following the March acquisition that transformed the formerly biotech-focused company into an operator with a major mineral-development platform in Greenland.

IGC Pharma Reaches 146-Patient Enrollment Target In Phase 2 Alzheimer’s Agitation Trial

By Amit Chowdhry ● Aug 19, 2026

IGC Pharma reached its previously disclosed 146-patient randomized enrollment target for the Phase 2 CALMA trial evaluating IGC-AD1 for agitation associated with Alzheimer's disease, moving the clinical program closer to database lock, site closeout, and eventual topline analysis.

Merck And Moderna’s Intismeran Plus KEYTRUDA Meets Phase 3 Melanoma Trial Endpoints

By Amit Chowdhry ● Aug 19, 2026

Merck and Moderna announced positive topline results from the Phase 3 INTerpath-001 trial evaluating intismeran autogene in combination with KEYTRUDA (pembrolizumab) as an adjuvant treatment for patients with completely resected Stage IIB-IV melanoma.

Oakley Capital Acquires Majority Stake In Graphwise As AI Knowledge Platform Grows ARR 30%+ Annually

By Amit Chowdhry ● Aug 19, 2026

Oakley Capital has acquired a majority stake in Graphwise, an enterprise AI knowledge platform provider serving more than 200 blue-chip customers, as the private equity firm looks to accelerate the company's international expansion and capitalize on growing demand for trusted data infrastructure supporting artificial intelligence.

Bridgenext Acquires CloudX, Increasing Engineering Headcount By 25% To Expand Enterprise AI Capabilities

By Amit Chowdhry ● Aug 19, 2026

Bridgenext has acquired CloudX, an enterprise AI software company based in Buenos Aires, expanding its AI, data and product engineering capabilities as businesses move from experimental AI projects toward broader enterprise deployments. The acquisition increases Bridgenext’s engineering headcount by 25% and significantly expands the company’s presence in Argentina.

Flip Raises $25 Million To Bring AI To Frontline Workers Across 1,000+ Brands

By Amit Chowdhry ● Aug 19, 2026

Flip has raised $25 million in new funding to expand its AI-native employee experience platform and provide frontline workers with greater access to digital identities, enterprise applications and automated workflows. Existing investors Notion Capital and HV Capital increased their stakes in the company, while L-Bank, the development bank of Baden-Württemberg, joined as a new investor.

Cribl Acquires Radiant Security’s AI SOC Technology As It Pushes Deeper Into $121 Billion Security Market

By Amit Chowdhry ● Aug 19, 2026

Cribl has acquired technology assets from Radiant Security’s AI-native security operations center product, expanding the company’s security capabilities with technology designed to autonomously triage, investigate and resolve security alerts. The acquisition includes intellectual property associated with Radiant Security’s AI SOC technology. Financial terms of the transaction were not disclosed.

Brinqa Acquires PlexTrac, Creating 3,000+ Customer Exposure Management Platform Used By 25%+ Of Fortune 500

By Amit Chowdhry ● Aug 19, 2026

Brinqa has acquired PlexTrac, adding offensive security validation, workflow and reporting capabilities to its exposure management platform and creating what the company describes as the largest standalone vendor in Unified Exposure Management. Financial terms of the transaction were not disclosed.

Relativity Networks Raises $22 Million And Lands $40 Million Hyperscaler Order For 47%-Faster AI Fiber

By Amit Chowdhry ● Aug 19, 2026

Relativity Networks has raised $22 million through a SAFE financing and secured a $40 million follow-on order from a major hyperscaler as the company scales its ChronoCore hollow-core fiber technology for geographically distributed AI infrastructure.

DocGo Raises SteadyMD Earnout Liability To $5 Million From $2.3 Million As Telehealth Revenue Outlook Improves

By Amit Chowdhry ● Aug 19, 2026

DocGo increased the estimated contingent consideration liability associated with its SteadyMD acquisition to $5 million from $2.3 million, recording a $2.7 million first-half fair-value loss because the company now expects stronger revenue performance from the acquired telehealth business.

OS Therapies Secures Up To $10 Million Debt Financing Against U.K. Tax Refunds And R&D Credits

By Amit Chowdhry ● Aug 19, 2026

OS Therapies secured up to $10 million of debt financing backed by expected U.K. VAT refunds and reimbursable R&D tax credits, including $5 million funded at an August 10 first closing, creating an unusual financing structure that converts expected recoveries from development spending into near-term liquidity.

AI Financial’s 7.28 Billion WLFI Tokens Fall To $421.3 Million, More Than $1 Billion Below Cost Basis

By Amit Chowdhry ● Aug 19, 2026

AI Financial Corporation's 7.28 billion WLFI tokens carried a fair value of $421.3 million at June 27, 2026, compared with a $1.457 billion cost basis, leaving the World Liberty Financial token position approximately $1.04 billion below its original cost.

Nasus Pharma Targets Q4 Pivotal Study For Intranasal Epinephrine In $2 Billion Market, With Topline Data Expected Q1 2027

By Amit Chowdhry ● Aug 19, 2026

Nasus Pharma plans to begin a pivotal clinical study of its NS002 intranasal epinephrine powder in Q4 2026, with topline data expected in Q1 2027, positioning the company for a major clinical catalyst in an anaphylaxis market it estimates at approximately $2 billion and currently dominated by injectable products.

C Street Adds Deneese Walia Levin From Kirkland & Ellis To Expand Law Firm Optimization Practice

By Amit Chowdhry ● Aug 19, 2026

C Street Advisory Group has appointed Deneese Walia Levin as Managing Director of Law Firm Optimization, bringing more than two decades of legal and operational experience from Kirkland & Ellis as law firms increasingly face questions about AI, technology, talent, governance, and strategic positioning.

InspireMD Targets $9 Million Of Annual Cost Savings As CGuard TCAR Study Reports 100% Acute Device Success

By Amit Chowdhry ● Aug 19, 2026

InspireMD initiated cost-reduction actions expected to generate approximately $9 million of annual savings as it prepares for an anticipated U.S. CGuard platform relaunch, while its CGUARDIANS II study reported 100% acute device success across all 50 patients evaluated with the CGuard Prime 80 cm implant in TCAR procedures.

NexMetals Mining: Selkirk CuEq Inventory Rises About 70% As Strip Ratio Falls To 1.02:1

By Amit Chowdhry ● Aug 19, 2026

NexMetals Mining increased the contained copper-equivalent metal inventory at its Selkirk project in Botswana by approximately 70%, while reducing the conceptual open-pit strip ratio to 1.02:1 from 1.65:1, combining a significantly larger resource base with potentially less waste movement per tonne of mineralized material.

SOL Strategies’ HoudiniSwap Generates CAD$1.2 Million Revenue And More Than 60% EBITDA Margin In First Month

By Amit Chowdhry ● Aug 19, 2026

SOL Strategies reported approximately CAD$1.2 million of swap-aggregator fee revenue from HoudiniSwap during just one month of operations in fiscal Q3 2026, giving the company its first reported financial contribution from the privacy and cross-chain execution business acquired during the quarter.

Terra Innovatum Targets Up To 8 MWe Of SOLO Nuclear Capacity For Data Centers In Argentina And Brazil

By Amit Chowdhry ● Aug 19, 2026

Terra Innovatum Global advanced an initial commercial pathway for up to 8 MWe of behind-the-meter SOLO micro-modular nuclear capacity supporting data-center facilities in Argentina and Brazil, providing one of the first quantified commercial deployment opportunities disclosed for its reactor platform.

Empire Petroleum Revenue Rises 27% Despite 23% Production Decline As Adjusted EBITDA Turns Positive

By Amit Chowdhry ● Aug 19, 2026

Empire Petroleum increased Q2 2026 product revenue 27% to $11.1 million despite a 23% decline in net equivalent sales volumes, while adjusted EBITDA improved to positive $365,000 from a loss of $1.18 million a year earlier.

AMC Robotics: Recurring AI And Cloud Revenue Rises 54% As Company Moves Away From Inventory-Heavy Sales

By Amit Chowdhry ● Aug 19, 2026

AMC Robotics reported 54% year-over-year growth in recurring AI and cloud revenue-sharing revenue during Q2 2026 as the company deliberately reduced lower-margin, inventory-intensive product sales in favor of AI, cloud and service-based revenue.

Cloudastructure: Subscribing Properties Jump 140% As Gross Profit Rises 53% And Operating Loss Widens

By Amit Chowdhry ● Aug 19, 2026

Cloudastructure increased the number of subscribing properties by 140% year over year in Q2 2026, while quarterly revenue increased just 14% to $1.23 million. Gross profit rose approximately 53% to $610,000, although higher sales, marketing and operating spending caused its operating loss to widen.

NRx Starts Manufacturing 5 Million Ketamine Launch Doses Before FDA Approval Decision

By Amit Chowdhry ● Aug 19, 2026

NRx Pharmaceuticals has begun commercial-scale manufacturing of 5 million doses of preservative-free ketamine for potential commercialization in 2026, putting launch inventory into production while its abbreviated new drug application remains under FDA review.

Duos Announces More Than $611 Million Of AI Data Center Contracts Tied To 65 MW Of Capacity

By Amit Chowdhry ● Aug 19, 2026

Duos Technologies has announced AI and data-center agreements representing more than $611 million of contracted value tied to 65 MW of capacity, dramatically increasing the scale of the company’s commercial commitments as it completes its transformation into an AI infrastructure provider.

Flexsteel Records 11th Consecutive Quarter Of Sales Growth Even As Q4 Revenue Rises 0.7%

By Amit Chowdhry ● Aug 19, 2026

Flexsteel Industries recorded its 11th consecutive quarter of year-over-year sales growth in fiscal Q4 2026 even though quarterly net sales increased just 0.7%, illustrating the furniture company’s ability to keep its growth streak intact amid continued weakness in consumer furniture demand.

SINOVAC: Overseas Revenue Jumps 82% To $66.5 Million And Reaches 45% Of Total Sales

By Amit Chowdhry ● Aug 19, 2026

SINOVAC’s overseas revenue rose 82.3% to $66.5 million in the first half of 2026 and reached about 45.2% of total sales, making international markets the primary driver of the vaccine maker’s revenue growth as demand for some products remained pressured in mainland China.

DeepCyte Launches 300,000-Cell AI Toxicity Atlas As Pharma Pilots Advance With 3 Top-20 Drugmakers

By Amit Chowdhry ● Aug 19, 2026

DeepCyte has launched DeeTox Atlas, a proprietary single-cell metabolomic reference atlas designed to help pharmaceutical companies predict drug toxicity mechanisms earlier in the discovery process. The company said the platform is the world's first single-cell metabolomic reference atlas focused on drug toxicity mechanisms.

FORT Robotics To Go Public At $556.6 Million Enterprise Value With About $201 Million In Expected Proceeds

By Amit Chowdhry ● Aug 18, 2026

FORT Robotics has agreed to go public through a business combination with Newbury Street II Acquisition Corp., valuing the combined physical AI safety company at an implied pro forma enterprise value of $556.6 million.